1. Introduction {#s0005}
===============

Inflammation plays a critical role in the pathogenesis of type 2 diabetes ([@bb0175]). The elevation of plasma inflammatory cytokines (IL-1β and IL-6) precedes the development of type 2 diabetes ([@bb0185]). Inflammation occurs not only systemically, but also locally within insulin-sensitive tissues (e.g., liver and skeletal muscle) and the pancreas. Inflammatory cytokines act locally to interfere with insulin signaling at sites where they are produced, and local inflammation can induce β cell dysfunction and subsequent insulin deficiency in the pancreatic islets of subjects with type 2 diabetes mellitus ([@bb0175], [@bb0055]).

Cigarette smoking is an environmental factor that potently induces an inflammatory response. It is known that smokers have higher levels of circulating inflammatory cytokines, such as IL-6, IL-8 and TNF-α, than nonsmokers ([@bb0085], [@bb0025], [@bb0155]). In an in vitro study, cigarette smoke condensate treatment increased the expression levels of the *IL-1β* and *IL-8* genes in normal human bronchial epithelial cells, in which the degree of *IL-1β* gene induction was greatest among the six cytokines examined ([@bb0080]). The chemical species derived from smoking, such as nicotine and cotinine, are detected in various biological samples including saliva, hair, blood and urine ([@bb0120]), thus indicating that the toxic chemical species derived from cigarette smoke are absorbed from the lung capillaries and spread throughout the whole body to all organs, including insulin-sensitive tissues and the pancreas.

Polymorphisms in inflammatory genes have been shown to be involved in the modulation of the circulating inflammatory protein levels, such as C-reactive protein and IL-6 ([@bb0150], [@bb0095], [@bb0130]). Furthermore, it has been suggested that the degree of inflammatory response to cigarette smoking may differ according to individual\'s genotype for inflammatory genes ([@bb0095]). Although both external (i.e., cigarette smoking) and internal (i.e., inflammatory-related gene polymorphisms) factors regulating inflammation have been shown to be associated with the development of type 2 diabetes and/or insulin resistance, respectively ([@bb0105], [@bb0125], [@bb0205], [@bb0170], [@bb0210], [@bb0060], [@bb0110], [@bb0005], [@bb0020]), the interactions between inflammatory polymorphisms and smoking on the glycemic control remain to be elucidated. The glycated hemoglobin (HbA~1c~) level reflects the mean plasma glucose level over the preceding 2--3 months ([@bb0165]), and this clinical index is commonly used to obtain a diagnosis of diabetes.

The purpose of the current study was to investigate possible gene--environment interactions between several inflammation-related gene polymorphisms and cigarette smoking on the HbA~1c~ levels in the Japanese general population. We therefore conducted the current cross-sectional study to test the hypothesis that the association of cigarette smoking on the HbA~1c~ levels would be modified by polymorphisms of genes that encode inflammatory cytokine proteins.

2. Materials and methods {#s0010}
========================

2.1. Subjects {#s0015}
-------------

In the current cross-sectional study, we analyzed data for 4512 Japanese subjects 40--69 years of age who voluntary participated in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study during the period of 2005--2008. The study subjects were recruited from 10 different areas throughout Japan. The J-MICC study was launched in 2005 to confirm and detect gene--environment interactions involved in the development of lifestyle-related diseases in the Japanese general population, and the details of this cohort are described in detail elsewhere ([@bb0065], [@bb0200]). The J-MICC study was conducted in accordance with the ethical guidelines for epidemiological research of the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan. Written informed consent was obtained from all participants, and the study protocol was approved by the Ethics Committees at the Nagoya University Graduate School of Medicine and other institutions participating in the J-MICC study.

2.2. Questionnaire and measurements {#s0020}
-----------------------------------

Data on cigarette smoking, alcohol consumption, dietary habits, physical activity, as well as current medications and past disease history, were collected using a self-administered questionnaire. As for the smoking status, the subjects were first asked about their smoking status from the past to the present. Then, the current smokers were requested to report their usual cigarette consumption (cigarettes/day). The smoking status was categorized as never, former, current 1--19, or ≥ 20 cigarettes/day. In the present study, current smokers who smoked \< 20 cigarettes/day were described as moderate smokers, while current smokers who smoked ≥ 20 cigarettes/day were described as heavy smokers. The total energy intake and ethanol consumption were calculated using data obtained via a validated short food frequency questionnaire (FFQ) ([@bb0190], [@bb0195], [@bb0090]). Ethanol consumption was categorized as never, former, current 0.1--22.9, 23.0--45.9 or ≥ 46 g/day. The amount of habitual physical activity more than an intensity corresponding to 3 metabolic equivalents (METs) was assessed as previously described ([@bb0070]). A first-degree family history of diabetes was categorized as positive, negative or unknown. Anthropometric measurements and blood sampling were conducted as part of the health checkup or for research purposes at the institutions participating in the J-MICC study ([@bb0065]). Height and weight were measured to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index (BMI) was determined by dividing body weight in kilograms by the square of height in meters. The HbA~1c~ level was measured using a latex aggregation immunoassay (Japan Diabetes Society \[JDS\] value). The HbA~1c~ value was estimated as the National Glycohemoglobin Standardization Program (NGSP) equivalent value calculated according to the following formula: HbA~1c~ (NGSP \[%\]) = 1.02 × HbA~1c~ (JDS \[%\]) + 0.25% ([@bb0100]). A significantly elevated HbA~1c~ (high-normal HbA~1c~) level may be a superior clinical index for predicting the development of type 2 diabetes ([@bb0015]). An HbA~1c~ level of 5.7% was used as a cut-off value to define a high-normal 5.7% ([@bb0075]).

2.3. Genotyping {#s0025}
---------------

One hundred and seven single-nucleotide polymorphisms were genotyped using an Invader assay (Third Wave Technologies, Madison, WI, USA) ([@bb0135]) at the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, as previously described ([@bb0200]). Among 107 single-nucleotide polymorphisms, we selected eight polymorphisms in seven inflammatory genes for the current analyses (*IL-1β*: T-31C \[rs1143627\], *IL-2*: T-330G \[rs2069762\], *IL-4*: T-33C \[rs2070874\], *IL-8*: T-251A \[rs4073\], *IL-10*: T-819C \[rs1800871\], *IL-13*: C-1111T \[rs1800925\], *TNF-α*: T-1031C \[rs1799964\] and *TNF-α*: C-857T \[rs1799724\]). The genotype distributions of these eight polymorphisms did not deviate from Hardy--Weinberg equilibrium (*P* \> 0.05) ([@bb0200]). The *IL-6* C-634G polymorphism (rs1800796) was not selected because its genotype distribution deviated from Hardy--Weinberg equilibrium (*P* \< 0.05) ([@bb0200]).

2.4. Statistical analysis {#s0030}
-------------------------

In the current analysis, 1893 subjects were excluded due to following reasons: missing data on gene polymorphisms (*IL-1β*: n = 2, *IL-2*: n = 6, *IL-4*: n = 2, *IL-8*: n = 27, *IL-10*: n = 11, *IL-13*: n = 4, *TNF-α* T-1031C: n = 1, and *TNF-α* C-857T: n = 2), cigarette smoking status (n = 5), HbA~1c~ (n = 1763), taking type 2 diabetes medications (n = 193) or having a dietary energy intake extraordinarily greater than 4000 kcal/day (n = 2). Consequently, 2619 subjects in seven investigation areas remained for the current analysis. Among these 2619 participants, there were subjects with missing data regarding alcohol consumption (20 males and 22 females), physical activity (9 males and 14 females), height (1 male), weight (1 male) and BMI (1 male).

The statistical analyses were performed using the SAS software program (version 9.3 for Windows, SAS Institute, Cary, NC, USA). A *P* value of \< 0.05 was considered to be statistically significant. Sex differences in baseline characteristics were examined using the *t* test for continuous variables or chi-square test for categorical variables. Because of the low frequency of current smokers among females, males and females were analyzed together and sex was included as an adjusted factor in the following multivariate analyses. Multiple linear and logistic regression analyses were performed to calculate the regression coefficients (β) and evaluate the associations (*P* trend) between the cigarette smoking status (as an independent variable) and either the HbA~1c~ level or a high-normal HbA~1c~ value (≥ 5.7%) (as dependent variables) according to each genotype of the eight polymorphisms. Adjustment was made for the following potential confounding factors: sex (categorical), age (continuous), BMI (continuous), energy intake (continuous), physical activity (continuous), alcohol drinking (categorical), first-degree family history of diabetes mellitus (categorical) and investigation site (categorical). The smoking status was coded as follows: never (0), former (1), current moderate (2) or current heavy (3), treated as a continuous variable. Then, to identify gene polymorphism(s) that can modify the associations between cigarette smoking and the HbA~1c~ level, interactions with gene polymorphisms were assessed by including an interaction term, indicated as "gene polymorphism (categorical)\*smoking status (continuous)." The genotypes of the each polymorphism were coded as 0 for homozygous genotype, 1 for heterozygous genotype or 2 for the opposite homozygous genotype.

Given that our current purpose was to identify inflammatory polymorphisms that can modify the association of cigarette smoking with the HbA~1c~ level, and the interaction analysis was statistically significant only for the *IL-1β* T-31C polymorphism among the eight polymorphisms ([Table 2](#t0010){ref-type="table"}), the subsequent analyses focused on the *IL-1β* T-31C polymorphism. The significance of univariate correlations between either the *IL-1β* T-31C polymorphism or smoking status and selected characteristics (e.g., age and BMI) was assessed according to Spearman\'s rank correlation coefficient. In the correlation analysis, a family history of diabetes was orderly coded as 0 (negative), 1 (unknown), or 2 (positive). To assess the associations of the *IL-1β* T-31C polymorphism and smoking status with the HbA~1c~ level, the adjusted mean value of HbA~1c~ and its 95% confidence interval (CI) according to the *IL-1β* T-31C genotype or smoking status group were computed as least square means using the general linear model procedure with the LSMEANS statement in SAS. In these analyses, adjustment was made for sex and age (model 1), with additional adjustment for BMI, energy intake, physical activity, alcohol drinking, first-degree family history of diabetes mellitus, investigation site, smoking status (for the evaluation of the influence of the *IL-1β* T-31C polymorphism on the HbA~1c~ level) or *IL-1β* T-31C polymorphism (for the evaluation of the influence of the smoking status on the HbA~1c~ level) (model 2). Similarly, the odds ratios (ORs) and 95% CIs of the *IL-1β* T-31C polymorphism and smoking status for a high-normal HbA~1c~ value (≥ 5.7%) were estimated using logistic regression models adjusted for confounding factors, as described above.

Furthermore, an analysis of covariance (ANCOVA) was used to calculate the adjusted mean HbA~1c~ value (and 95% CI) and compare the levels between the smoking status groups within each *IL-1β* T-31C genotype. In order to conduct a similar analysis on the risk of a high-normal HbA~1c~ level, the ORs for high-normal HbA~1c~ and their 95% CIs were also calculated using never smokers in each genotype as a reference group.

3. Results {#s0035}
==========

3.1. Characteristics of the study subjects {#s0040}
------------------------------------------

The characteristics of the study participants are shown in [Table 1](#t0005){ref-type="table"}. Age was similar between males and females, while both BMI and energy intake were statistically significantly higher in males than females (*P* \< 0.01). Cigarette smoking and alcohol drinking were more prevalent among males than females (*P* \< 0.01). The percentages of participants who had a first-degree family history of diabetes were similar between the sex groups, while the HbA~1c~ levels were significantly higher in males than females (*P* \< 0.01).

3.2. Interaction of inflammatory gene polymorphisms and cigarette smoking on the HbA~1c~ level and a high-normal HbA~1c~ value {#s0045}
------------------------------------------------------------------------------------------------------------------------------

Among the eight gene polymorphisms investigated, only one statistically significant interaction was found for the *IL-1β* T-31C polymorphism (*P* interaction \< 0.0001), in which the *P* value was statistically significant even after using Bonferroni correction (Bonferroni-corrected *P* \< 0.0063) ([Table 2](#t0010){ref-type="table"}). None of the interactions between the other seven polymorphisms and cigarette smoking on the HbA~1c~ level were statistically significant (*IL-2*: *P* = 0.66, *IL-4*: *P* = 0.78, *IL-8*: *P* = 0.08, *IL-10*: *P* = 0.09, *IL-13*: *P* = 0.50, *TNF-α* T-1031C: *P* = 0.74, and *TNF-α* C-857T: *P* = 0.74). A similar pattern of results was obtained from the logistic regression analyses with respect to the risk of a high-normal HbA~1c~ value, although the *P* value was marginal for the interaction between the *IL-1β* T-31C polymorphism and cigarette smoking on a high-normal HbA~1c~ value (*P* interaction = 0.056).

3.3. Associations of the IL-1β T-31C polymorphism and cigarette smoking status with selected characteristics {#s0050}
------------------------------------------------------------------------------------------------------------

[Table 3](#t0015){ref-type="table"} shows the univariate associations of the *IL-1β* T-31C polymorphism and smoking status with the six selected characteristics. The T allele of the *IL-1β* T-31C polymorphism was significantly and positively correlated with BMI and alcohol drinking. The current smokers had higher BMI values, higher energy intake and higher percentages of current drinkers and subjects with a first-degree family history of diabetes.

3.4. Associations between the IL-1β T-31C polymorphism and smoking status on the HbA~1c~ levels {#s0055}
-----------------------------------------------------------------------------------------------

[Table 4](#t0020){ref-type="table"} shows the adjusted mean of the HbA~1c~ level and ORs for a high-normal HbA~1c~ value according to the *IL-1β* T-31C polymorphism or smoking status. The *IL-1β* T-31C polymorphism was not significantly associated with the HbA~1c~ levels, whereas the smoking status was significantly and positively associated with the HbA~1c~ levels following adjustment for all confounding factors (model 2 for HbA~1c~). The current heavy smokers had the highest OR for a high-normal HbA~1c~ value (1.30 \[95% CI 0.90--1.89\]) in comparison to never smokers, although the difference between these ORs did not reach statistical significance.

3.5. Stratified analyses according to the IL-1β T-31C genotypes {#s0060}
---------------------------------------------------------------

As shown in [Fig. 1](#f0005){ref-type="fig"}A, the adjusted HbA~1c~ levels in the subjects carrying the C allele (CC or CT) were similar among the four different smoking status groups (CC: never 5.52 \[95% CI 5.46--5.57\] %, former 5.42 \[5.32--5.52\] %, current moderate 5.41 \[5.24--5.58\] %, current heavy 5.53 \[5.39--5.67\] %; CT: never 5.49 \[5.45--5.53\] %, former 5.51 \[5.45--5.57\] %, current moderate 5.49 \[5.39--5.60\] %, and current heavy 5.49 \[5.40--5.58\] %). In contrast, among the individuals carrying the TT genotype, the HbA~1c~ levels were significantly higher in heavy smokers (5.83 \[5.67--5.99\] %) than in all other smoking status groups (never 5.49 \[5.41--5.56\] %, former 5.54 \[5.43--5.65\] % and current moderate 5.50 \[5.30--5.69\] %). A similar pattern of results was observed regarding a high-normal HbA~1c~ value ([Fig. 1](#f0005){ref-type="fig"}B). The high-normal HbA~1c~ risk (adjusted OR) was significantly higher in the subjects carrying the TT genotype (never 1.00 \[reference\], former 1.21 \[0.71--2.08\], current moderate 1.35 \[0.63--2.87\] and current heavy 2.16 \[1.14--4.10\]), whereas the ORs were similar among the participants with the C allele (CC: never 1.00 \[reference\], former 0.85 \[0.44--1.64\], current moderate 0.39 \[0.11--1.41\] and current heavy 1.22 \[0.57--2.64\]; CT: never 1.00 \[reference\], former 1.46 \[0.96--2.22\], current moderate 1.18 \[0.61--2.27\] and current heavy 0.88 \[0.48--1.62\]).

3.6. Separate analyses according to sex {#s0065}
---------------------------------------

Since the smoking rate in females was low in the current subjects, additional subanalyses on the interaction between cigarette smoking and *IL-1β* T-31C polymorphism on HbA~1c~ values were performed for males and females. While interactions between the *IL-1β* T-31C polymorphism and cigarette smoking on the HbA~1c~ levels were not significant in females alone (HbA~1c~: *P* interaction = 0.80; high-normal HbA~1c~: *P* interaction = 0.65), significant interactions were observed when analyzed in males alone (HbA~1c~: *P* interaction = 0.0016; high-normal HbA~1c~: *P* interaction = 0.0796). As shown in [Table 5](#t0025){ref-type="table"}, adjusted HbA~1c~ and high-normal HbA~1c~ values in male subjects showed a similar pattern to that for males and females combined.

4. Discussion {#s0070}
=============

In the current study, we investigated whether the influence of cigarette smoking on the HbA~1c~ levels varied according to polymorphisms of inflammatory genes in a middle-aged Japanese population. Of the eight gene polymorphisms examined, only one statistically significant interaction was detected for the *IL-1β* T-31C polymorphism (*P* interaction \< 0.0001). The association between cigarette smoking and the HbA~1c~ levels in subjects carrying C allele (CT or CC genotype) did not reach statistical significance, whereas the smoking status was positively associated with higher levels of HbA~1c~ in the individuals harboring the TT genotype (*P* trend = 0.001). A similar pattern of results was observed regarding the risk of high-normal HbA~1c~. Therefore, the current results suggest that heavy smokers with the TT genotype of the *IL-1β* T-31C polymorphism may show a greater adverse effect of smoking on the HbA~1c~ levels among middle-aged Japanese subjects.

As mentioned in the introduction, the *IL-1β* gene expression response to cigarette smoking condensate was highest compared with several inflammation-related genes ([@bb0080]), therefore we presumed that its high reactivity to smoking could be a reason for the sole significant interaction detected in the current study. IL-1β is a major proinflammatory cytokine that is known to be produced from endothelial or epithelial cells and macrophages and plays a central role in the regulation of inflammatory responses ([@bb0020]). IL-1β adversely affects peripheral insulin sensitivity; however, it is especially well known to be closely involved in the impairment of β-cells in pancreatic islets ([@bb0020]). There are clinical reports showing that blocking the biological activity of IL-1β (via the administration of IL-1-receptor antagonist or IL-1β-specific antibody) improves both the HbA~1c~ level and insulin secretion, but not peripheral insulin sensitivity ([@bb0115], [@bb0040], [@bb0180]).

*IL-1β* mRNA is primarily synthesized as an inactive precursor IL-1β (called pro-IL-1β) and the immature protein is then digested by the proteolytic enzyme caspase 1 to produce a biologically active mature form of IL-1β ([@bb0035]). The *IL-1β* T-31C is a TATA-box polymorphism that profoundly affects DNA-protein interactions in vitro; the -31T allele has been shown to have a 5-fold enhanced binding activity with the transcription initiation factor by way of preserving TATA-box ([@bb0045]). Similarly, another study showed that the -31T allele is associated with a 10-fold increase in the transcriptional activity compared with the -31C allele ([@bb0030]). Therefore, although the current subjects carrying the TT genotype might have had higher IL-1β production and may be susceptible to high HbA~1c~ levels, as shown in [Table 4](#t0020){ref-type="table"}, an increase in the T allele alone was not significantly associated with higher HbA~1c~ levels. This result does not support the concept that *IL-1β* plays an important role in controlling the blood glucose level ([@bb0185], [@bb0005], [@bb0020]).

However, the current results showed that overlap of the *IL-1β* T-31C TT genotype and heavy smoking (≥ 20 cigarettes/day) may be unfavorably linked to higher HbA~1c~ levels, as shown in [Fig. 1](#f0005){ref-type="fig"} and [Table 5](#t0025){ref-type="table"}. There is a possible explanation for these results. It has been demonstrated in an animal study that cigarette smoke exposure increases the proteolytic caspase 1 activity as well as release of mature (biologically active) IL-1β ([@bb0050]). Therefore, the current heavy smokers carrying the TT genotype might have demonstrated enhanced proteolytic cleavage of immature IL-1β by caspase 1, presumably activated by their heavy smoking, in pancreatic islets, in addition to preserving the increased synthesis of the IL-1β precursor due to the -31T genotype. Hence, we speculate that the coincidence of these two undesirable properties (i.e., the *IL-1β* T-31C TT genotype and heavy smoking) may lead to impaired insulin secretion, which can worsen the HbA~1c~ level.

The present result, namely that cigarette smoking was positively associated with higher HbA~1c~ levels only when adjusted for BMI (as shown in model 2 for the HbA~1c~ levels in [Table 4](#t0020){ref-type="table"}), is consistent with a previous report indicating that heavy smoking has a protective effect regarding the future development of type 2 diabetes, mainly through the protection from obesity ([@bb0145]). It is well known that smoking has innumerable harmful effects on overall health in addition to a detrimental influence on the blood glucose level; smoking cessation should be highly encouraged among all current smokers, regardless of their distinct *IL-1β* T-31C genotype. However, achieving smoking cessation is quite cumbersome, assumingly because of the effects of nicotine dependence or addiction and/or insufficient motivation or drive to quit smoking. The current research provides evidence that smoking is especially harmful to individuals bearing the *IL-1β* T-31C TT genotype from the perspective of type 2 diabetes prevention, and this information may help individuals with the *IL-1β* T-31C TT genotype to avoid starting smoking or possibly consider smoking cessation. Therefore, the present findings are expected to contribute to the development of individualized smoking cessation programs based on a person\'s genetic background.

The current study is associated with several limitations. First, since we excluded participants currently using type 2 diabetes medications (n = 193) from the present analyses in order to avoid potential reversal of cause and effect, we were unable to assess the influence on the development of type 2 diabetes. Second, we have no replication data accompanying this study. Confirmation of the present findings by other researchers is expected in the future. Third, although we speculated that the higher levels of HbA~1c~ noted in the current heavy smokers having the *IL-1β* T-31C TT genotype may be attributed to insulin deficiency, we have no data on the circulating insulin concentrations. Additionally, the expression levels of the *IL-1β* gene in pancreatic β cells were not investigated, as performing a needle biopsy of the pancreas is impracticable in epidemiological studies. Finally, it should be noted that smoking may beneficially affect individuals harboring autoimmune activation ([@bb0140], [@bb0010], [@bb0160]), however, we had pertinent no data to identify such individuals in the current population.

5. Conclusion {#s0075}
=============

We found an interaction between the *IL-1β* T-31C polymorphism and the cigarette smoking status regarding the HbA~1c~ levels, as heavy smokers harboring the TT genotype of *IL-1β* T-31C may exhibit a greater adverse effect of cigarette smoking on the HbA~1c~ levels. The smoking status did not interact with any other inflammation-related polymorphisms except IL-1β T-31C. Further studies are needed to confirm the current results in different subject populations and understand the precise mechanisms underlying this interaction.
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###### 

Characteristics of study subjects by sex. The J-MICC Study 2005--2008.

Table 1

  ---------------------------------------------------------------------------------------------------------------------------------------
  (n = 2619)                                                       Males\        Females\      *P*[a](#tf0005){ref-type="table-fn"}
                                                                   (n = 1274)    (n = 1345)    
  ---------------------------------------------------------------- ------------- ------------- ------------------------------------------
  Age (years)                                                      57.3 ± 8.6    56.9 ± 8.4    0.30

  Height (cm)[b](#tf0010){ref-type="table-fn"}                     166.8 ± 6.1   154.0 ± 5.5   \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  Weight (kg)[b](#tf0010){ref-type="table-fn"}                     66.1 ± 9.9    53.7 ± 7.6    \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  BMI (kg/m^2^)[b](#tf0010){ref-type="table-fn"}                   23.7 ± 3.0    22.6 ± 3.1    \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  Energy intake (kcal/day)                                         1949 ± 355    1561 ± 259    \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  Physical activity (MET h/day)[c](#tf0015){ref-type="table-fn"}   13.4 ± 13.2   12.7 ± 11.5   0.17

  Smoking, n (%)                                                                               

   Never                                                           348 (27.3)    1202 (89.4)   \< 0.01[⁎](#tf0025){ref-type="table-fn"}

   Former                                                          563 (44.2)    57 (4.2)      

   Current moderate 1--19 cigarettes/day                           119 (9.3)     54 (4.0)      

   Heavy ≥ 20 cigarettes/day                                       244 (19.2)    32 (2.4)      

  Drinking, n (%)[d](#tf0020){ref-type="table-fn"}                                             

   Never                                                           267 (21.3)    856 (64.7)    \< 0.01[⁎](#tf0025){ref-type="table-fn"}

   Former                                                          28 (2.2)      23 (1.7)      

   Current 0.1--22.9 g/day                                         450 (35.9)    389 (29.4)    

   23.0--45.9 g/day                                                262 (20.9)    37 (2.8)      

   46.0 + g/day                                                    247 (19.7)    18 (1.4)      

  Family history of diabetes, n (%)                                189 (14.8)    215 (16.0)    0.36

  HbA~1c~ (%)                                                      5.54 ± 0.64   5.48 ± 0.49   \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  TC (mg/dL)                                                       205 ± 32      219 ± 35      \< 0.01[⁎](#tf0025){ref-type="table-fn"}

  HDL-C (mg/dL)                                                    58 ± 16       68 ± 16       \< 0.01[⁎](#tf0025){ref-type="table-fn"}
  ---------------------------------------------------------------------------------------------------------------------------------------

Values are expressed as the means ± standard deviation for continuous variables or number (percentage) for categorical variables. BMI, body mass index; MET, metabolic equivalent; HbA~1c,~ glycated hemoglobin; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol.

*P* values for sex differences are based on *t* tests for continuous variables and chi-square tests for categorical variables.

Based on 1273 males.

Based on 1265 males and 1331 females.

Based on 1254 males and 1323 females.

*P* \< 0.05.

###### 

Associations of smoking with HbA~1c~ or high-normal HbA~1c~ by each genotype of inflammatory polymorphisms, and interactions between smoking and gene polymorphism on the HbA~1c~ levels. The J-MICC Study 2005--2008.

Table 2

  -------------------------------------------------------------------------------------------------------------------------------------------------------
  Polymorphism       Genotype        HbA~1c~    High-normal HbA~1c~                                                                                
  ------------------ --------------- ---------- --------------------- -------- -------------------------------------------- -------- ------ ------ ------
  *IL-1β* T-31C\     CC (n = 584)    − 0.0040   0.0254                0.88     \< 0.0001[⁎](#tf0040){ref-type="table-fn"}   0.01     0.13   0.96   0.06
  \[rs1143627\]                                                                                                                                    

  CT (n = 1274)      − 0.0004        0.0166     0.98                  − 0.02   0.09                                         0.81                   

  TT (n = 761)       0.0963          0.0292     0.001                 0.24     0.10                                         0.02                   

  *IL-2*T-330G\      TT (n = 1166)   0.0191     0.0214                0.37     0.66                                         0.10     0.09   0.28   0.54
  \[rs2069762\]                                                                                                                                    

  TG (n = 1172)      0.0363          0.0189     0.05                  0.12     0.09                                         0.18                   

  GG (n = 281)       0.0533          0.0306     0.08                  − 0.21   0.20                                         0.29                   

  *IL-4*T-33C\       TT (n = 1181)   0.0305     0.0197                0.12     0.78                                         0.02     0.09   0.84   0.96
  \[rs2070874\]                                                                                                                                    

  TC (n = 1162)      0.0193          0.0206     0.35                  0.11     0.09                                         0.24                   

  CC (n = 276)       0.0450          0.0318     0.16                  0.17     0.19                                         0.38                   

  *IL-8*T-251A\      AA (n = 1205)   0.0456     0.0197                0.02     0.08                                         0.09     0.09   0.29   0.97
  \[rs4073\]                                                                                                                                       

  AT (n = 1150)      0.0124          0.0186     0.51                  0.07     0.09                                         0.42                   

  TT (n = 264)       0.0768          0.0484     0.11                  0.10     0.19                                         0.61                   

                                                                                                                                                   

  *IL-10*T-819C\     TT (n = 1149)   0.0301     0.0198                0.13     0.09                                         0.09     0.09   0.29   0.82
  \[rs1800871\]                                                                                                                                    

  CT (n = 1165)      0.0419          0.0212     0.05                  0.05     0.09                                         0.61                   

  CC (n = 305)       − 0.0059        0.0287     0.84                  0.11     0.18                                         0.53                   

  *IL-13* C-1111T\   TT (n = 87)     − 0.0294   0.0525                0.58     0.50                                         − 0.75   0.59   0.20   0.41
  \[rs1800925\]                                                                                                                                    

  TC (n = 785)       0.0421          0.0240     0.08                  0.12     0.11                                         0.29                   

  CC (n = 1747)      0.0277          0.0163     0.09                  0.06     0.07                                         0.41                   

  *TNF-α* T-1031C\   TT (n = 1857)   0.0318     0.0157                0.04     0.74                                         0.07     0.07   0.31   0.82
  \[rs1799964\]                                                                                                                                    

  CT (n = 691)       0.0312          0.0262     0.23                  0.04     0.11                                         0.74                   

  CC (n = 71)        − 0.0103        0.0522     0.84                  − 0.06   0.45                                         0.89                   

  *TNF-α* C-857T\    CC (n = 1745)   0.0310     0.0158                0.05     0.74                                         0.07     0.07   0.30   0.67
  \[rs1799724\]                                                                                                                                    

  CT (n = 784)       0.0348          0.0258     0.18                  0.08     0.12                                         0.51                   

  TT (n = 90)        − 0.0132        0.0775     0.87                  0.26     0.42                                         0.54                   
  -------------------------------------------------------------------------------------------------------------------------------------------------------

HbA~1c~, glycated hemoglobin; IL, interleukin; TNF, tumor necrosis factor; SE, standard error.

β indicates regression coefficient of multiple regression between smoking (independent variable) and either HbA~1c~ or high-normal HbA~1c~ (dependent variables).

Interaction with smoking status.

*P* \< 0.05.

###### 

Selected characteristics of the subjects by *IL-1β* (T--31C) genotypes or cigarette smoking status. The J-MICC Study 2005--2008.

Table 3

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                                         *IL-1β* (T--31C)   Smoking status                                                                                                 
  ------------------------------------------------------- ------------------ ---------------- ------ ------ ------------------------------------------ ------ ------ ------ ------ -------- ------------------------------------------
  BMI (kg/m^2^)[c](#tf0055){ref-type="table-fn"}          23.1               23.1             23.4   0.05   \< 0.01[⁎](#tf0070){ref-type="table-fn"}   22.9   23.7   22.6   23.8   0.10     \< 0.01[⁎](#tf0070){ref-type="table-fn"}

  Energy intake (kcal/day)                                1737               1745             1766   0.03   0.08                                       1668   1889   1789   1871   0.28     \< 0.01[⁎](#tf0070){ref-type="table-fn"}

  Physical activity\                                      13.1               13.0             13.0   0.00   0.91                                       13.1   12.3   13.3   13.9   − 0.05   0.01[⁎](#tf0070){ref-type="table-fn"}
  (MET·hours/day)[d](#tf0060){ref-type="table-fn"}                                                                                                                                          

  Current smokers (%)                                     15.9               17.1             18.1   0.04   0.06                                       --                                   

  Current drinkers (%)[e](#tf0065){ref-type="table-fn"}   50.2               55.4             56.2   0.04   0.04[⁎](#tf0070){ref-type="table-fn"}      41.1   76.2   70.2   70.6   0.39     \< 0.01[⁎](#tf0070){ref-type="table-fn"}

  First-degree family history of diabetes (%)             14.9               15.9             15.1   0.02   0.28                                       15.2   14.0   16.8   18.8   0.04     0.03[⁎](#tf0070){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data values are expressed as the means. IL, interleukin; BMI, body mass index; MET, metabolic equivalent.

Spearman\'s rank correlation coefficients between either *IL-1β* polymorphism or smoking status and six selected characteristics.

*P* values for the Spearman\'s rank correlations.

Based on 2618 subjects.

Based on 2596 subjects.

Based on 2577 subjects.

*P* \< 0.05.

###### 

Adjusted means of BMI (kg/m^2^), HbA~1c~ (%) or odds ratios for high-normal HbA~1c~ (≥ 5.7%) according to the *IL-1β* (T--31C) genotypes or cigarette smoking status. The J-MICC Study 2005--2008.

Table 4

                                                   *IL-1β* (T--31C)    Smoking status                                                                                                                                     
  ------------------------------------------------ ------------------- ------------------- ------------------- --------- ------ ------------------- ------------------- ------------------- ------------------- --------- ---------------------------------------
  *Adjusted means of BMI*                                                                                                                                                                                                 
  Model 1[b](#tf0080){ref-type="table-fn"}         23.1 (22.9--23.4)   23.1 (22.9--23.2)   22.3 (23.1--23.5)   0.120     0.15   23.2 (23.0--23.4)   23.2 (22.9--23.5)   22.4 (21.9--22.9)   23.4 (23.0--23.8)   − 0.019   0.79
  Model 2[c](#tf0085){ref-type="table-fn"}         23.1 (22.9--23.4)   23.1 (22.9--23.3)   23.3 (23.1--23.5)   0.080     0.34   23.2 (23.0--23.3)   23.3 (23.0--23.5)   22.5 (22.0--22.9)   23.4 (23.0--23.8)   − 0.011   0.87
                                                                                                                                                                                                                          
  *Adjusted means of HbA~1c~*                                                                                                                                                                                             
  Model 1[b](#tf0080){ref-type="table-fn"}         5.49 (5.45--5.54)   5.50 (5.47--5.53)   5.53 (5.49--5.57)   0.022     0.16   5.50 (5.47--5.54)   5.50 (5.45--5.55)   5.45 (5.37--5.54)   5.58 (5.51--5.65)   0.017     0.20
  Model 2[c](#tf0085){ref-type="table-fn"}         5.50 (5.45--5.54)   5.50 (5.47--5.53)   5.53 (5.49--5.57)   0.016     0.29   5.49 (5.46--5.53)   5.50 (5.45--5.55)   5.47 (5.39--5.56)   5.61 (5.54--5.68)   0.030     0.02[⁎](#tf0090){ref-type="table-fn"}
                                                                                                                                                                                                                          
  *Adjusted odds ratios for high-normal HbA~1c~*                                                                                                                                                                          
  Model 1[b](#tf0080){ref-type="table-fn"}         1.00 (reference)    0.95 (0.76--1.20)   1.01 (0.78--1.30)   0.007     0.91   1.00 (reference)    1.17 (0.90--1.54)   0.83 (0.54--1.25)   1.08 (0.77--1.53)   − 0.001   0.99
  Model 2[c](#tf0085){ref-type="table-fn"}         1.00 (reference)    0.95 (0.74--1.21)   0.98 (0.75--1.28)   − 0.009   0.90   1.00 (reference)    1.24 (0.92--1.65)   1.04 (0.66--1.63)   1.30 (0.90--1.89)   0.070     0.24

Values are expressed as the adjusted means or odds ratios (95% confidence interval). BMI, body mass index; HbA~1c~, glycated hemoglobin; IL, interleukin.

Regression coefficients for the associations between either *IL-1β* (T--31C) polymorphism or cigarette smoking status and HbA~1c~ levels.

Model 1: adjusted for sex and age.

Model 2: adjusted for Model 1 and further adjusted for BMI (for the association between either IL-1β polymorphism or smoking status and HbA~1c~ levels), energy intake, physical activity, alcohol drinking, family history of diabetes mellitus, investigation site, smoking status (for the association of *IL-1β* polymorphism with HbA~1c~ levels) and *IL-1β* polymorphism (for the association of smoking with HbA~1c~ levels).

*P* \< 0.05.

###### 

Influence of cigarette smoking on the HbA~1c~ levels according to the *IL-1β* T-31C genotypes in male subjects. The J-MICC Study 2005--2008.

Table 5

  *IL-1β* (T--31C) genotypes                       Smoking status      β[a](#tf0095){ref-type="table-fn"}   *P* trend                                          
  ------------------------------------------------ ------------------- ------------------------------------ ------------------- ------------------- ---------- ------------------------------------------
  *Adjusted means of HbA~1c~*                                                                                                                                  
  CC (n = 263)                                     5.55 (5.43--5.66)   5.47 (5.38--5.56)                    5.50 (5.29--5.72)   5.52 (5.38--5.66)   − 0.0053   0.86
  CT (n = 612)                                     5.49 (5.42--5.56)   5.52 (5.46--5.57)                    5.54 (5.42--5.66)   5.48 (5.40--5.57)   0.0001     1.00
  TT (n = 399)                                     5.48 (5.31--5.65)   5.59 (5.45--5.72)                    5.54 (5.23--5.85)   5.90 (5.69--6.10)   0.1279     \< 0.01[⁎](#tf0100){ref-type="table-fn"}
                                                                                                                                                               
  *Adjusted odds ratios for high-normal HbA~1c~*                                                                                                               
  CC (n = 263)                                     1.00 (reference)    1.17 (0.53--2.58)                    0.41 (0.08--2.22)   1.19 (0.45--3.18)   0.0068     0.97
  CT (n = 612)                                     1.00 (reference)    1.53 (0.92--2.54)                    1.80 (0.82--3.96)   0.95 (0.48--1.91)   0.0064     0.95
  TT (n = 399)                                     1.00 (reference)    1.75 (0.94--3.28)                    2.04 (0.79--5.32)   2.61 (1.23--5.55)   0.2982     0.013[⁎](#tf0100){ref-type="table-fn"}

Values are expressed as the adjusted means or odds ratios (95% confidence interval). HbA~1c~, glycated hemoglobin; IL, interleukin. Adjusted for sex, age, body mass index, energy intake, physical activity, alcohol drinking, family history of diabetes mellitus and investigation site.

Regression coefficients for the associations between cigarette smoking status and HbA~1c~ levels.

*P* \< 0.05.
